Healthtracka, a health startup located in Nigeria, has successfully raised $1.5 million in its seed round to improve inclusive healthcare systems not only in Nigeria but also outside its borders.
The company plans to put the financing toward expanding its Business to Business as well as its Business to Company offering, which would allow partner organizations in Nigeria to provide at-home testing services to their employees, as well as accelerating the company’s growth beyond its present reach.
Among the investors who took part in this early-stage round is the venture fund Hustle Fund, which is based in the United States, venture capital firm Ingressive Capital, which focuses on Africa, and Investors from the angel community, including Flying Doctors and Alumni Angels Alliance.
In May of 2021, Victor Amusan and Ifeoluwa Dare-Johnson founded Healthtracka to address the shortage of medical infrastructure and personnel prevalent in Africa.
The eHealth platform provides patients with at-home health services and diagnostic test results that are simple to read and deliver to them within three days. The medical procedure as a whole is made less stressful by the new health company because it uses technology to do screening tests in the convenience of its customers’ homes.
The health startup claims to have outstanding laboratory associates that are the finest in pathology laboratories, with laboratories with the highest possible accreditations such as MLSCN and ISO certifications. It also claims that its partners are the best in their respective fields.
Before the end of the year, the company intends to launch its subscription plans for retail customers and also provide APIs for pharmacies, hospitals, and telehealth service providers that can give at-home blood testing for their patients, and expand its operations further than Nigeria to Ghana and Kenya.
Since its inception, Healthtracka’s community of phlebotomy technicians has multiplied by 20 and now numbers over 100. Additionally, the fledgling company has brought almost 7,000 tests to customers’ homes and is experiencing revenue growth of 30 per cent month-over-month.